XML 21 R8.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Feb. 27, 2022
Feb. 28, 2021
Mar. 01, 2020
Cash flows from operating activities:      
Net earnings $ 8,464 $ 4,864 $ 9,552
Loss from discontinued operations, net of tax 0 328 653
Net earnings from continuing operations 8,464 5,192 10,205
Adjustments to reconcile net earnings to net cash provided by operating activities:      
Depreciation and amortization 1,136 1,150 1,544
Stock-based compensation 285 191 726
Allowance for bad debt 16 16 41
Provision for deferred income taxes 894 (56) 849
Amortization of bond premium 956 543 27
Loss (gain) on sale of marketable securities 10 (10) (15)
Loss on sale of fixed assets 27 0 0
Non-cash restructuring 0 1,318 0
Accounts receivable (722) 3,276 (1,614)
Inventories 137 1,585 (1,112)
Prepaid expenses and other current assets (550) 157 490
Other assets and liabilities 111 250 3,348
Accounts payable (766) (1,435) 1,566
Accrued liabilities (214) (1) (1,211)
Income taxes payable (1,583) 1,164 (8,973)
Net cash provided by operating activities - continuing operations 8,201 13,340 5,871
Net cash used in operating activities - discontinued operations 0 (328) (653)
Net cash provided by operating activities 8,201 13,012 5,218
Cash flows from investing activities:      
Purchases of property, plant and equipment (4,372) (7,493) (6,846)
Proceeds from sales of property, plant and equipment 14 0 0
Purchases of marketable securities (59,422) (83,941) (104,600)
Proceeds from sales and maturities of marketable securities 34,224 124,392 68,935
Net cash (used in) provided by investing activities - continuing operations (29,556) 32,958 (42,511)
Net cash provided by investing activities - discontinued operations 0 0 0
Net cash (used in) provided by investing activities (29,556) 32,958 (42,511)
Cash flows from financing activities:      
Dividends paid (8,168) (8,153) (28,721)
Proceeds from exercise of stock options 739 12 417
Purchase of treasury stock 0 (1,644) 0
Net cash used in financing activities - continuing operations (7,429) (9,785) (28,304)
Net cash used in financing activities - discontinued operations 0 0 0
Net cash used in financing activities (7,429) (9,785) (28,304)
(Decrease) increase in cash and cash equivalents before effect of exchange rate changes - continuing operations (28,784) 36,513 (64,944)
(Decrease) in cash and cash equivalents before effect of exchange rate changes - discontinued operations 0 (328) (653)
(Decrease) increase in cash and cash equivalents before effect of exchange rate changes (28,784) 36,185 (65,597)
(Decrease) increase in cash and cash equivalents (28,784) 36,185 (65,597)
Cash and cash equivalents, beginning of year 41,595 5,410 71,007
Cash and cash equivalents, end of year $ 12,811 $ 41,595 $ 5,410